Evidence-Based Complementary and Alternative Medicine

Evidence-Based Complementary and Alternative Medicine / 2016 / Article

Retraction | Open Access

Volume 2016 |Article ID 9676590 | https://doi.org/10.1155/2016/9676590

Evidence-Based Complementary and Alternative Medicine, "Retracted: Sagunja-Tang Improves Lipid Related Disease in a Postmenopausal Rat Model and HepG2 Cells", Evidence-Based Complementary and Alternative Medicine, vol. 2016, Article ID 9676590, 1 page, 2016. https://doi.org/10.1155/2016/9676590

Retracted: Sagunja-Tang Improves Lipid Related Disease in a Postmenopausal Rat Model and HepG2 Cells

Received24 Mar 2016
Accepted24 Mar 2016
Published31 Mar 2016

The article titled “Sagunja-Tang Improves Lipid Related Disease in a Postmenopausal Rat Model and HepG2 Cells” [1] has been retracted at the request of the authors as it was found to be similar to the following previously published article: “Palmiwon attenuates hepatic lipid accumulation and hyperlipidemia in a menopausal rat model,” by Hiroe Go, Jin Ah Ryuk, Hye Won Lee, and Byoung Seob Ko, in Menopause: The Journal of The North American Menopause Society: 2015, Volume 22, Issue 8, pp. 872–884.

References

  1. H. Go, J. A. Ryuk, H. W. Lee et al., “Sagunja-tang improves lipid related disease in a postmenopausal rat model and HepG2 cells,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 321407, 13 pages, 2015. View at: Publisher Site | Google Scholar

Copyright © 2016 Evidence-Based Complementary and Alternative Medicine. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views830
Downloads357
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.